TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By The Schall Law Firm
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is pursuing a class action lawsuit against Telix Pharmaceuticals for allegedly making false and misleading statements about its prostate cancer therapeutic candidates and supply chain between February and August 2025.

Insights
TLX   negative

The company is accused of overstating its progress with therapeutic candidates and artificially inflating the quality of its supply chain, which led to potential investor damages